Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Arimidex anastrozole: Phase III data

Preliminary 1-year data from the international Phase III IBIS-2 Bone Sub Study showed that women with normal BMD who received Arimidex had significantly

Read the full 239 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE